Condition: Advanced Solid Tumors · Ewing Sarcoma · Hepatocellular Carcinoma (HCC) · Sponsor: SEED Therapeutics, Inc.
A Phase 1/1B Study of ST-01156 in Patients with Advanced Solid Malignancies
This description comes directly from the study's public registry record.
Dr. Eric Rowinsky Chief Medical Officer · (908) 883-0647 · erowinsky@oncodrugs.com
Always discuss trial participation with your own doctor first.
| The City of Hope National Medical Center | Duarte, California, United States | Recruiting |
| Hoag Memorial Hospital | Newport Beach, California, United States | Recruiting |
| Mass General Brigham Cancer Institute | Boston, Massachusetts, United States | Recruiting |
| Dana Farber Cancer Institute | Boston, Massachusetts, United States | Recruiting |
| Memorial Sloan Kettering Cancer Center | New York, New York, United States | Recruiting |
| The University of Texas MD Anderson Cancer Center | Houston, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07197554